Psyched Wellness Ltd (TSE:PSYC) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Psyched Wellness Ltd., specializing in health and wellness products derived from the Amanita Muscaria mushroom, has successfully completed its final tranche of a non-brokered private placement, raising US$2.5 million with support from Gotham Green Partners. The total capital raised through this initiative has reached US$7.5 million, which the company plans to use for working capital and general corporate purposes. The final tranche involved the issuance of 48,889,284 Units, with each unit comprising a common share and a warrant, under specific terms outlined in previous releases.
For further insights into TSE:PSYC stock, check out TipRanks’ Stock Analysis page.